ArticleNature communications2025
Stabilizing the excited states of organic phosphorescent photosensitizers via self-assembly for CO
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Natural Photosensitizers in Cancer Therapy: A Chemo-Biodiversity Perspective on Light-Activated Natural Compounds.Chemistry & biodiversity · 2026Review
- Supramolecular dye polymers for aggregation-induced photocatalysis.Nature chemistry · 2026Article
- Sulfonated Ionic Covalent Organic Frameworks With Dual-State Activation for Synergistic Photodynamic-Ferroptosis Therapy.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Research Progress on Nano-Drug Delivery Systems for Photothermal Cancer Therapy.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The development of pure organic photosensitizers remains challenging due to the low intersystem crossing efficiency and the instability of triplet excitons. Herein, fused-ring phosphorescent molecules enhance visible-light absorption, with heteroatom-rich structures breaking the restriction of low triplet excitons. A derivative, 2,3,5,6,9,10-hexabutoxy-8-phenyldithieno-tribenzo-pyridine (TPy), exhibits high ISC efficiency and efficiently sensitizes Fe-catalysts for CO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.